Advanced Breast Cancer

Transcription

1 Bridging the Gap Advanced Breast Cancer Fifth ESO-ESMO International Consensus Conference November 2019 lisbon, Portugal Coordinating Chair: F. Cardoso, PT Chairs: E.P. Winer, US - L. Norton, US - A. Costa, IT/CH Co-Chairs: G. Curigliano, IT - S.A. Mertz, US Scientific Committee Members: K. Gelmon, CA - F. Penault-Llorca, FR E. Senkus, PL - C. Thomssen, DE The ABC5 guidelines will be developed by ESO and ESMO The ABC5 conference and guidelines are endorsed by The ABC5 conference is held under the auspices of with official representatives of and is endored by FEDERACIÓN LATINOAMERICANA DE MASTOLOGIA 2018 ABC5 will be followed by the meeting on November 2019 second ANNouNCemeNt ANd CAll for ABstrACts

2 Affiliated with the European Society of Breast Cancer Specialists Official Journal of the Breast Centres Network Advanced Breast Cancer Fifth ESO-ESMO International Consensus Conference dates and team By 6 may 2019 By 20 may 2019 By 20 may 2019 By 28 July 2019 By 27 october 2019 from 28 october 2019 ABC Award nominations Abstract submission Travel grant applications Early registration Late registration On-site registration Dolores Knupfer (2) dknupfer@eso.net Submit online at Luis Carvalho (2) lcarvalho@eso.net Dolores Knupfer (2) dknupfer@eso.net Register online at Laura Richetti (2) lrichetti@eso.net Luis Carvalho (2) lcarvalho@eso.net By 8 November 2019 Accommodation and Optional tours Helder Carvalho (3) helder.carvalho@abreu.pt Dedicated media partner Organisation, exhibition, satellite symposia and sponsorship Programme Social Media Communication ABC Global Alliance Francesca Marangoni (1) fmarangoni@eso.net Dolores Knupfer (2) dknupfer@eso.net Corinne Hall (1) chall@eso.net Gabriele Maggini (2) gmaggini@eso.net Roberta Ventura (2) rventura@eso.net Partner journal THE BREAST An Associate Journal of the Australasian Society for Breast Disease 1 European School of Oncology Via Turati Milano, Italy 2 European School of Oncology Piazza Indipendenza Bellinzona, Switzerland 3 Viagens Abreu SA Av. 25 de Abril, Linda-a-Velha, Portugal ph fx ph fx ph fx ABC November 2019 LISBON, PORTUGAL

3 #ABClisbon foreword dear Colleagues, The International Consensus Conference for Advanced Breast Cancer (ABC) has established itself as the major international conference for advanced Breast Cancer. Its primary goal is the development of international consensus guidelines for the management of ABC patients. These guidelines are based on the most up-todate evidence and can be used to guide treatment decision making in many different health care settings globally, with the necessary adaptations due to different access to care. The last meeting, which took place in Lisbon, Portugal in November 2017, brought together participants from 89 countries around the world, including health professionals, patient advocates and journalists. We believe that health professionals working closely together with patient advocates and with the strong support of the media can raise awareness about the needs and challenges faced by this traditionally underserved and forgotten group of patients. ABC also aims to identify research priorities based on the most important areas of unmet needs, analyse and discuss available data to provide the most accurate management recommendations, as well as influence policy makers and funding bodies and ultimately improve standards of care, survival and quality of life. Research and education, with accurate usage of available knowledge, throughout the world, are key to achieve these goals. The creation of the ABC Global Alliance, also provides a platform for the development of important projects, aiming to strongly impact on the survival and quality of life of advanced breast cancer patients. ABC guidelines are jointly developed by ESO (European School of Oncology) and ESMO (European Society of Medical Oncology) and guidelines or ABC conferences have been endorsed and supported by several other international oncology organizations such as EUSOMA (European Society of Breast Cancer Specialists), ESTRO (European Society for Radiotherapy and Oncology), ESGO (European Society of Gynaecological Oncology), UICC (Union International Contre le Cancer), SIS (Senologic International Society)/ISS (International School of Senology), FLAM (Federacion Latino-Americana de Mastologia), OECI (Organization of European Cancer Institutes), EONS (European Oncology Nursing Society), AGO (Arbeitsgemeinschaft Gynäkologische Onkologie e. V.), Susan G. Komen and BCRF (Breast Cancer Research Foundation) and have official representation from ASCO. It is therefore with great enthusiasm that we invite you to attend the Advanced Breast Cancer Fifth ESO-ESMO International Consensus Conference (ABC5) that will take place in Lisbon, Portugal, on November Together we will improve the lives of all brave ABC patients. fatima Cardoso, Coordinating Chair LISBON, PORTUGAL November 2019 ABC5 3

4 Advanced Breast Cancer Fifth ESO-ESMO International Consensus Conference General information Attendance ABC1 (November 2011) was attended by 800 participants from 64 countries, ABC2 (November 2013) by more than 1,000 participants from 71 countries, ABC3 (November 2015) by more than 1,200 participants from 84 countries, ABC4 (November 2016) about 1,300 participants from 89 countries. 1,400 participants are expected to ABC5. Venue ABC5 will be held at the CCL - Centro de Congressos de Lisboa, Praça das Industrias, Lisbon, Portugal. official language The official language is English. No translation will be provided. Insurance The organisers bear no responsibility for untoward events in relation to the participation at the Conference. Participants are advised to take out their own personal and travel insurance coverage. Abstract book The abstract book will be published as a supplement of The Breast and contain abstracts from the invited lecturers and those submitted by the participants that have been accepted for oral or poster presentation or for publication only. Cme accreditation and certificates Participants will be entitled to receive a certificate of attendance at the close of the Conference by completing the evaluation questionnaire. Application for CME recognition will be submitted to ESMO for ESMO-MORA accreditation, to the Accreditation Council of Oncology in Europe (ACOE) and the European Accreditation Council for Continuing Medical Education (EACCME), an institution of the European Union of Medical Specialists (UEMS). EACCME credits are recognised by the American Medical Association towards the Physician s Recognition Award (PRA). Information on the status of the application can be obtained from the organising secretariat. social media Tweet, network and follow updates using #ABClisbon on Twitter and Facebook. filming, recording or photographing Conference sessions All sessions except the Consensus session: Filming, recording and non-flash photograph of speakers are permitted. Filming, recording and photography of slides are not permitted without the presenter s permission. Consensus session: Filming, recording and photography are prohibited since the contents of the statements will be revised when published in the consensus paper. other areas of the Conference: Filming, recording and photography are permitted if prior permission has been given by the press officers. Filming, recording and photography of posters are not permitted without the author s permission. third party media policy The policy applies to all activities related to the news media during or in connection with ABC5 and is posted at The aim is to ensure that information distributed to the journalists is accurate and is issued at the correct times, complying with any embargoes that may be in place. The policy applies to media events that are organised at the ABC5 venue and off-site, and all third parties are requested to adhere. official carrier TAP Portugal, a Star Alliance member, is pleased to be appointed as the ABC5 Official Carrier and offers discounts (10% on economy and 15% on business class fares) to participants who make their flight booking on TAP Portugal flights through TAP Portugal s website. To make the booking, the participant should follow these steps: enter the website select flights and dates (dates should be within 10 days before and 10 days after the event) insert the event code It19tPCG14 in the Promotion/Congress Code Box, located on the left side of the webpage Please note that bookings made previously through travel agencies or at TAP desks and code-share flights operated by other airlines are not eligible for the TAP discounts. 4 ABC November 2019 LISBON, PORTUGAL

5 #ABClisbon ABC5 scientific Committee Coordinating chair fatima Cardoso Breast Unit, Champalimaud Clinical Center, Lisbon, PT scientific Committee members Karen Gelmon BC Cancer Agency, Vancouver, CA frédérique Penault-llorca Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, FR elzbieta senkus Medical Universtity of Gdansk, Gdansk, PL Chairs eric P. Winer Breast Oncology Center, Dana-Farber Cancer Institute, Boston, US larry Norton Breast Cancer Programs, Memorial Sloan-Kettering Cancer Centre, New York, US Alberto Costa European School of Oncology, Milan, IT and Bellinzona, CH Co-chairs Giuseppe Curigliano European Institute of Oncology, Milan, IT Christoph thomssen Martin-Luther-Universität, Klinikum Kröllwitz, Halle (Saale), DE shirley A. mertz Metastatic Breast Cancer Network US, Inverness, US Invited faculty (as of October 2018) matti s. Aapro IMO Clinique de Genolier, Institut Multidisciplinare d Oncologie, Genolier, CH Bertha Aguilar lopez Salvati, Mexico City, MX fabrice André Department of Medical Oncology, Gustave Roussy Institute, Villejuif, FR Carlos H. Barrios (tbd) Department of Medicine, PUCRS School of Medicine, Porto Allegre, BR Jonas Bergh Department of Oncology-Pathology, Karolinska Institute, Stockholm, SE Gouri s. Bhattacharyya Department of Medical Oncology, Fortis Hospital, Kolkata, IN laura Biganzoli Department of Medical Oncology, Sandro Pitigliani Oncology Centre, Prato, IT Anna Cabanes Susan G. Komen, Washington, US maria João Cardoso Breast Unit, Champalimaud Cancer Center and MamaHelp, Lisbon, PT lisa A. Carey Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center, North Carolina, US LISBON, PORTUGAL November 2019 ABC5 5

6 Advanced Breast Cancer Fifth ESO-ESMO International Consensus Conference Javier Cortés Ramón y Cajal University Hospital, Madrid & Vall d'hebron Institute of Oncology (VHIO), Madrid, ES Carsten denkert Institute of Pathology, Charité Medical University, Berlin, DE Alexandru eniu Department of Breast Tumors, Cancer Institute "I. Chiricuta", Cluj-Napoca, RO Nagi s. el saghir NK Basile Cancer Institute, American University of Beirut Medical Center, Beirut, LB lesley fallowfield Sussex Health Outcomes Research & Education in Cancer, Brighton & Sussex Medical School, University of Sussex, Brighton, UK Prudence A. francis Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, AU Joseph Gligorov Department of Medical Oncology, Cancer Est APHP Tenon, University Paris VI, Paris, FR uwe Güth Breast Centre, Zurich, CH renate Haidinger Brustkrebs Deutschland e.v., Munich, DE Nadia Harbeck Breast Centre, University of Munich, Munich, DE Xichun Hu Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, CN Bella Kaufman Oncology Institute, Sheba Medical Center, Tel Hashomer, IL ranjit Kaur Breast Cancer Welfare Association, Selangor, MY Belinda Kiely NHMRC Clinical Trials Centre, Sydney Medical School, Sydney, AU sung-bae Kim Asan Medical Centre, University of Ulsan College of Medicine, Department of Oncology, Seoul, KR frédéric lecouvet Dept of Radiology, Centre du Cancer and Institut de Recherche Expérimentale et Clinique (IREC), Cliniques Universitaires Saint Luc, Université Catholique de Louvain, Brussels, BE Nancy u. lin US Breast Oncology Center, Dana-Farber Cancer Institute, Boston, US sabine linn The Netherlands Cancer Institute, Amsterdam, NL danni manzi Breast Cancer Care, London, UK Gertrude Nakigudde Uganda Women's Cancer Support Organisation, Kampala, UG silvia Neciosup Department of Medical Oncology, National Institute of Neoplastic Diseases, Lima, PE Birgitte V. offersen Department of Oncology, Aarhus University Hospital, DK shinji ohno Breast Oncology Centre, Cancer Institute Hospital, Tokyo, JP olivia Pagani Breast Unit, Oncology Institute of Southern Switzerland, Bellinzona, CH shani Paluch-shimon Oncology Institute, Shaare Zedek Medical Centre, Jerusalem, IL evi Papadopoulos Europa Donna, Nicosia, CY Gabriella Pravettoni European Institute of Oncology, Milan, IT Aleix Prat Hospital Clínic of Barcelona, University of Barcelona, Barcelona, ES shawna rich-ginsberg Rethink Breast Cancer, Toronto, CA Carla ripamonti Supportive Care Unit, National Tumour Institute, Milan, IT Hope s. rugo Breast Oncology and Clinical Trials Education, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, US Peter schmid Centre for Experimental Cancer Medicine, Barts Cancer Institute, London, UK George W. sledge Division of Oncology, Stanford School of Medicine, Stanford, US danielle spence Breast Cancer Network Australia, Camberwell, AU Andrew tutt Division of Breast Cancer Research and Breast Cancer Now Toby Robins Research Centre, Institute of Cancer Reaserch and Guy s Hospital King s College London, UK daniel A. Vorobiof Sandton Oncology Centre, Johannesburg, ZA Binghe Xu Department of Medical Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College,Beijing, CN 6 ABC November 2019 LISBON, PORTUGAL

7 #ABClisbon ABC5 conference and consensus guidelines The ABC guidelines are jointly developed by eso and esmo and are published in Annals of Oncology journal. The Conference and guidelines are endorsed by eusoma, flam and sis. The Conference is furthermore held under the auspiced oeci, uicc, with official representatives of AsCo and is endorsed by AGo, eons and estro. Further leading organisations in the field will cooperate and endorse the Conference and guidelines. The guidelines from previous editions are published at and Breast cancer patient advocacy programme representatives of breast cancer patient advocacy groups are warmly invited to participate in ABC5 and actively contribute to the scientific programme and consensus session. Furthermore, in collaboration with several leading breast cancer patient advocacy groups worldwide, specific additional patient advocacy sessions will be scheduled. Breast Cancer Patient Advocacy Committee Coordinator: fatima Cardoso ABC Global Alliance, Lisbon, PT Bertha Aguilar lopez Salvati, Mexico City, MX Anna Cabanes Susan G. Komen, Washington, US maria João Cardoso MamaHelp Association, Lisbon, PT renate Haidinger Brustkrebs Deutschland e.v., Munich, DE ranjit Kaur Breast Cancer Welfare Association, Selangor, MY danni manzi Breast Cancer Care, London, UK shirley A. mertz Metastatic Breast Cancer Network US, Inverness, US Gertrude Nakigudde Uganda Women s Cancer Support Organisation, Kampala, UG evi Papadopoulos Europa Donna, Nicosia, CY shawna rich-ginsberg Rethink Breast Cancer, Toronto, CA danielle spence Breast Cancer Network Australia, Camberwell, AU LISBON, PORTUGAL November 2019 ABC5 7

8 Advanced Breast Cancer Fifth ESO-ESMO International Consensus Conference Preliminary programme schedule 8 ABC November 2019 LISBON, PORTUGAL

9 #ABClisbon Preliminary programme thursday, 14 November :00-10:30 Audit.II 9:00-10:30 10:30-11:00 11:00-12:30 I 11:00-12:30 12:30-13:30 13:30-14:30 14:30-16:00 16:00-16:20 Patient advocacy session (TBD) Sponsored satellite symposium (TBD) Coffee break Patient advocacy session (TBD) Sponsored satellite symposium (TBD) Lunch Opening session Chairs: Fatima Cardoso, PT and Larry Norton, US - Welcome to lisbon Local authorities - opening and introduction Fatima Cardoso, PT - Keynote lecture (tbd) Meaningful clinical benefit: How to define, evaluate and communicate Chairs: Bella Kaufman, IL and Shirley A. Mertz, US - Applying the esmo-mbcs to ABC systemic therapies Shani Paluch-Shimon, IL - optimal endpoints for ABC clinical trials: can we aim for more? Nadia Harbeck, DE - optimizing clinical trial designs in ABC: reaching relevant clinical benefit Speaker to be confirmed - estimating and communicating survival times for each ABC patient Belinda Kiely, AU - the role of big data and real-world data George W. Sledge, US - Panel discussion All Coffee break LISBON, PORTUGAL November 2019 ABC5 9

10 Advanced Breast Cancer Fifth ESO-ESMO International Consensus Conference 16:30-17:40 16:55-18:00 18:00-19:30 I 18:00-19:30 19:30 Best abstract presentations Chairs: Alberto Costa, IT/CH and Evi Papadopoulos, CY - Questions and Answers Discussing the hardest issues Chairs: Karen Gelmon, CA and Anna Cabanes, US - When to stop and who decides? Gabriella Pravettoni, IT - suicide and assisted suicide in ABC patients Uwe Güth, CHA - optimal end of life care Carla Ripamonti, IT - Panel discussion: how to support the terminal ill and family All Patient advocacy session (TBD) Sponsored satellite symposium (TBD) Welcome cocktail friday, 15 November :30-8:30 8:30-9:00 9:00-10:10 10:10-10:30 Sponsored satellite symposium (TBD) ABC Award and lecture Chair: Larry Norton, US - Awardee: To be announced Understanding and applying biology knowledge Chairs: Daniel A. Vorobiof, ZA and Gertrude Nakigudde, UG - Next generation sequencing for clinical decisions: friend or foe Fabrice André, FR - Is lobular ABC a separate entity? Sabine Linn, NL - de novo vs. recurrent ABC Prudence A. Francis, AU - Biomarkers for new approaches: what have we been doing wrong? Aleix Prat, ES - discussion Coffee break 10 ABC November 2019 LISBON, PORTUGAL

11 #ABClisbon 10:30-11:25 11:25-12:20 12:20-13:30 13:30-14:25 14:25-15:35 15:35-16:00 Latest news: Triple Negative ABC Chairs: Binghe Xu, CN and Danielle Spence, AU - standards of care and optimal options Hope S. Rugo, US - New targets, new drugs Andrew Tutt, UK - Biology and resistance Giuseppe Curigliano, IT - discussion Managing side effects and difficult symptoms Chairs: Jonas Bergh, SE and Renate Haidinger, DE - overcoming global hurdles in pain management: from morphine shortage to opioid abuse Matti S. Aapro, CH - Gynecological and sexual symptoms: the silent suffering Christoph Thomssen, DE - fatigue and cachexia: from biology to solutions Carlos H. Barrios, BR (TBD) - discussion Lunch and poster session Latest news: Luminal ABC Chairs: Nagi S. El Saghir, LB and Bertha Aguilar Lopez, MX - standards of care and optimal options Joseph Gligorov, FR - New targets, new drugs Peter Schmid, UK - Biology and resistance Carsten Denkert, DE - discussion Specific sites of metastases Chairs: Sung-Bae Kim, KR and Danni Manzi, UK - update on systemic therapy of brain metastases Nancy U. Lin, US - leptomeningeal disease Laura Biganzoli, IT - the role of new rt techniques for metastases treatment Birgitte V. Offersen, DK - discussion Coffee break LISBON, PORTUGAL November 2019 ABC5 11

12 Advanced Breast Cancer Fifth ESO-ESMO International Consensus Conference 16:00-17:00 17:00-18:00 18:00-19:30 I 18:00-19:30 Latest news: HER2+ ABC Chairs: Silvia Neciosup, PE and Ranjit Kaur, MY - standards of care and optimal options Lisa A. Carey, US - New targets, new drugs Javier Cortés, ES - Biology and resistance Frédérique Penault-Llorca, FR - discussion Improving monitoring of efficacy and toxicity Chairs: Olivia Pagani, CH and Shawna Rich-Ginsberg, CA - Implementing Proms in clinical research and clinical practice Lesley Fallowfield, UK - optimal imaging techniques for bone only disease Frédéric E. Lecouvet, BE - the role of liquid biopsies Speaker to be confirmed - discussion Patient advocacy session (TBD) Sponsored satellite symposium (TBC) saturday, 16 November :30-10:30 10:30-11:00 11:00-11:15 11:15-12:45 12:45-13:00 Consensus session (part I) ABC5 Chairs, Scientific Committee members and Panellists Coffee break Report from ABC Patient Advocacy Committee Speaker to be announced Consensus session (part II) ABC5 Chairs, Scientific Committee members and Panellists Close 12 ABC November 2019 LISBON, PORTUGAL

13 #ABClisbon Consensus panellists Matti S. Aapro, CH Fabrice André, FR Carlos H. Barrios, BR (TBD) Jonas Bergh, SE Gouri S. Bhattacharyya, IN Laura Biganzoli, IT Lisa A. Carey, US Fatima Cardoso, PT Maria João Cardoso, PT Javier Cortés, ES Alberto Costa, IT/CH Giuseppe Curigliano, IT Nagi S. El Saghir, LB Alexandru Eniu, RO Lesley Fallowfield, UK Prudence A. Francis, AU Karen Gelmon, CA Joseph Gligorov, FR Nadia Harbeck, DE Renate Haidinger, DE Xichun Hu, CN Bella Kaufman, IL Ranjit Kaur, MY Belinda Kiely, AU Sung-Bae Kim, KR Nancy U. Lin, US Shirley A. Mertz, US Silvia Neciosup, PE Larry Norton, US Birgitte V. Offersen, DK Shinji Ohno, JP Olivia Pagani, CH Shani Paluch-Shimon, IL Evi Papadopoulos, CY Frédérique Penault-Llorca, FR Aleix Prat, ES Hope S. Rugo, US Elzbieta Senkus, PL George W. Sledge, US Christoph Thomssen, DE Daniel A. Vorobiof, ZA Eric P. Winer, US Binghe Xu, CN ABC Global Alliance the ABC Global Alliance, established by ESO, is a multi-stakeholder platform for all those interested in collaborating in common projects relating to advanced breast cancer. Launched during the World Cancer Congress in Paris in 2016 the Alliance is the continuation of the work developed through the ABC International Consensus Conference, responsible for the ESO-ESMO international consensus guidelines for the management of advanced breast cancer and its advocacy efforts. The goal is to improve and extend the lives of women and men living with ABC in all countries worldwide, to fight for a cure, to raise awareness of ABC and lobby worldwide for the improvement of the lives of ABC patients. Furthermore, please be informed that the ABC Global Alliance will hold its yearly meeting immediately after ABC5 on November For further information about the ABC Global Alliance, please contact Roberta Ventura, rventura@eso.net, ph LISBON, PORTUGAL November 2019 ABC5 13

14 Advanced Breast Cancer Fifth ESO-ESMO International Consensus Conference ABC Award Call for nominations The ABC Award is aimed at recognising a researcher, physician, nurse or patient advocate who has made an outstanding and impacting contribution in the field of advanced breast cancer throughout his/her career. The 2017 ABC Award in recognition of her work and dedication to advocacy specifically to advanced breast cancer patients - was assigned to musa mayer. The 2015 ABC Award - in recognition of his work on metastatic breast cancer, especially improving the management of metastatic cancer to bone, resulting in preservation and improvement in quality of life of patients worldwide - was assigned to robert e. Coleman. The 2013 ABC Award - in recognition of his work on discovering fundamental, clinically-relevant biological and molecular mechanisms for metastases including site specificity, latency, selfseeding and the role of the microenvironment in colonization and drug resistance - was assigned to Joan massagué. For the fourth ABC Award, nominations submitted by 6 may 2019 to dknupfer@eso.net will be assessed. Nomination process: The nominee must not have already received the ABC Award; The award recipient will be chosen on the basis of his/her accomplishment. No bearing will be given to his/her race, gender, nationality, religious or political views Nominees may not nominate themselves. If any of the members of the ABC Scientific Committee is nominated, he/she will excuse him/herself from all the nomination discussion, selection and approval. The final selection will be made by the ABC5 Scientific Committee. Nominations should be submitted through a letter which should: Be limited to words; Include a concise description of the candidate s accomplishments and a description of how this contribution has changed practice in the field of advanced breast cancer. The letter may refer to publications. biosketch of the nominated person The recipient will receive an award certificate and will be invited to make a presentation during ABC5. The outcome of the nominations will be communicated by 1 July ABC November 2019 LISBON, PORTUGAL

15 #ABClisbon Abstract submission Deadline for submission: 20 May 2019 Submit online at Participants are invited to submit abstracts on subjects related to advanced breast cancer in one of the categories listed below. Please note that all abstracts must relate to advanced (not early) breast cancer in order to be considered. Abstracts will be assessed for presentation at the Conference, either oral or poster, or for publication in the ABC5 Abstract Book, supplement of The Breast. The best abstracts will be selected for oral presentation within the programme with a 10-minute slide presentation followed by a 5-minute discussion slot. The best abstract oral presentations will be scheduled on Thursday, 14 November and poster presentations on Friday, 15 November. Categories Nursing Patient Advocacy Basic and translational research Clinical issues: Medical oncology Clinical issues: Radiation oncology Clinical issues: Surgical oncology Clinical issues: Supportive and palliative care Clinical issues: Other topics Instructions: The number of characters is limited: 250 characters for the title (lower case letters) and maximum 2800 characters for the body of the abstract. Names of research groups should appear in the title, not in the authors list. Tables and images are not accepted. List the authors affiliations. The same affiliation should be entered only once. The first author will be the corresponding author and the presenter at the conference. The full address with address, phone and fax numbers of the first author (= corresponding author and presenter) must be provided. The first author will receive an acknowledgement of receipt and all subsequent communication by . For abstracts accepted for presentation (oral or poster), the first author will be the presenting author and will be requested to register and participate in the conference. It is the responsibility of the first author to ascertain whether all authors are aware of the content of the abstract before submission is made. The acknowledgement of receipt of the abstract will immediately follow the submission. The outcome will be notified to the first author by 1 July 2019 who will be required to register to the conference (early registration deadline: 28 July 2019). LISBON, PORTUGAL November 2019 ABC5 15

16 Advanced Breast Cancer Fifth ESO-ESMO International Consensus Conference registration Online registration is available at Registration grants participation in all sessions, a copy of the Programme and of the Abstract Book, coffee breaks, lunches, welcome cocktail as indicated in the programme. Early (by 28 July 2019) Registration fee EUR 450 Late (by 27 October 2019) On-site (from 28 October 2019) Club ESO Members EUR 350 EUR 550 EUR 700 ESMO Members EUR 350 Cancellation Cancellation should be notified to ESO in writing. In case of cancellation without replacement, the fee minus EUR 100 for handling charges will be refunded within three months of the notification, provided that the cancellation is received by ESO before 15 September Replacements will be possible until 27 October Badge The badge is the only official evidence of registration and should be worn at all times during the event. Loss of badge results in loss of registration. Nurses and patient advocates Nurses and representatives of cancer patient advocacy non-profit organisations are eligible for a discounted registration fee: EUR 250 by 28 July 2019 EUR 300 by 27 October 2019 EUR 400 from 28 October 2019 and on-site. To register to the Conference, nurses and representatives of patient advocacy organisations should submit the following documents by the deadline: Registration form for nurses or patient advocates (available at Nurses: curriculum vitae with full contact details Patient advocates: curriculum vitae or resume indicating their advocacy experience, role within the organisation and the full contact details of the patient advocate s organisation. media registration The Conference welcomes representatives of print and electronic media. Registration is free of charge to journalists who are in possession of a valid, recognised press card. Freelance journalists must present a commissioning letter on headed paper from a recognised news organisation or publication. Representatives of advertising, marketing and public relations companies are not eligible for free media registration. A copy of the Press Card or of the commissioning letter should be sent together with the media representative registration form (available at Group registration The online group registration may be processed online for groups of 5 or more individuals. The procedure and deadlines are published at 16 ABC November 2019 LISBON, PORTUGAL

17 #ABClisbon travel grants A limited number of travel grants are made available on a competitive basis to: Physicians from low, lower middle and upper middle income economies as defined by The World Bank; Physicians under the age of 40; Nurses; Patient advocates. Full applications should be submitted on by 20 may 2019 providing the following documents: Physicians and nurses: An abstract submitted online according to the abstract submission procedure (deadline 20 May 2019, see page 10); Short curriculum vitae; Letter describing motivation for attending; Letter of endorsement by the Institute/Department director or head nurse. Patient advocates: Short curriculum vitae; Letter describing motivation for attending. Travel grant recipients will receive a set amount to contribute to their travel and accommodation expenses, whilst registration will be processed directly by the organisers. The following amounts will be refunded by bank transfer after the Conference: EUR 500 for participants coming from Europe, Middle-East and North-Africa; EUR for participants coming from other regions and overseas. The outcome of the application will be notified by 1 July Hotel accommodation Deadline for booking: 8 November 2019 Book online at Viagens Abreu has been designated as the official accommodation agency for ABC5 and offers discounted rates at selected hotels. In order to secure availability and the discounted rates, participants are kindly required to proceed with their bookings as soon as possible. Bookings are made on a first-come first-serve basis. The list of hotels, and information on public transportation and on optional tours are available at LISBON, PORTUGAL November 2019 ABC5 17

18 ABC November 2019 LISBON, PORTUGAL registration form Participant s details Dr. Prof. Mr. Mrs Family name Organisation Please fill in this form in block capitals and send by the deadline to: european school of oncology - Piazza Indipendenza, Bellinzona - Switzerland Luis Carvalho - Tel: Fax: lcarvalho@eso.net Laura Richetti - Tel: Fax: lrichetti@eso.net First name Department #ABClisbon Street Zip Code Town Country Phone Fax Mobile Date of birth Birth place (town and country) Profession Specialisation Main field VAT number (Compulsory for self-employed persons) Fiscal code (Italian residents only) Are you an esmo member? YES NO If YES: Membership ID: Expire date (DD/MM/YYYY): If your invoice details are different to those above, please complete the following section: Invoice contact details Address Phone VAT number (Compulsory for companies or self-employed persons) Fiscal code (Italian residents only) registration Early (by 28 July 2019) Late (by 27 October 2019) On-site (from 28 October 2019) Registration fee EUR 450 Club ESO Members EUR 350 EUR 550 EUR 700 ESMO Members EUR 350 Payment details The registration is processed when payment accompanies the form(credit card details or copy of bank transfer) Visa/Mastercard Card Number / / / Holder s name: Expiry date / CV2 code and signature BANK TRANSFER with no cost to the beneficiary (please provide a copy of the bank transfer): Bank: Banca Popolare di Milano, Agenzia 24 - Milan, Italy Account holder: European School of Oncology Number: No IBAN: IT96G BIC: BPMIITMMXXX reference: "ABC4" + your name I authorise the European School of Oncology and any possible partner organisations in the event to use my personal data according to what is specified in Article 13 DLGS 196, available at or on request at fax number Signature Date 24 online registration AVAIlABle At

19 Bridging the Gap milan Via Turati, Milano - Italy Phone: Fax: eso@eso.net Bellinzona Piazza Indipendenza, Bellinzona - Switzerland Phone: Fax: eso@eso.net